Skip to content

Acute Effects of Coffee on Appetite and Inflammation Markers, Glucose Metabolism and Energy Intake

Acute Effects of Caffeinated and Decaffeinated Coffee Consumption on Energy Intake, Appetite, Inflammation and Glucose Metabolism

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01174576
Enrollment
16
Registered
2010-08-03
Start date
2009-02-28
Completion date
2009-05-31
Last updated
2013-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health

Keywords

coffee, appetite, energy intake, inflammation, cortisol, glucose, randomized controlled trial

Brief summary

The purpose of the study is to investigate whether caffeinated and decaffeinated coffee consumption has acute effects on subjective appetite feelings, energy intake and biochemical markers related to appetite, inflammation and glucose metabolism compared to water consumption.

Detailed description

Coffee is a pharmacologically active, widely consumed beverage. Scientific interest in relation to coffee consumption has been revisited the last decade in the light of new, mainly epidemiological, evidence indicating its potential health benefits. In specific, both cross-sectional and prospective studies indicate that coffee consumption is associated with a lower risk for type 2 diabetes. Furthermore, an inverse association has been found between coffee consumption and markers of inflammation and endothelial dysfunction in healthy and/or diabetic participants, although the opposite effect has also been reported, mainly in relation to inflammation markers. In relation to body weight, epidemiological data suggest that increment in caffeine consumption is associated with lower mean weight gain and energy intake during a 12-y period. However, information from clinical studies is scarce. Acute caffeine and/or coffee consumption have been associated with impaired glucose metabolism and insulin resistance. In relation to inflammation, animal studies have indicated a beneficial or no effect of coffee consumption, whereas a clinical study in humans found an increase in adiponectin and a decrease in interleukin-18 (IL-18) blood concentrations after a monthly intervention including daily consumption of 8 cups of coffee. As far as energy balance is concerned, there is an early experiment demonstrating that the ingestion of 300 mg of caffeine prior to food intake, compared to the non-caffeine intake, significantly reduced energy intake by 21.7% in men, but not in women. A more recent study has found that the combination of caffeine and red pepper is positively associated with energy expenditure and negatively with energy intake, whereas, it has also been reported a positive association between habitual caffeine intake and body weight loss achieved through a very-low-calorie diet. Taking into consideration the limited clinical evidence regarding the acute effect of coffee consumption on appetite-related markers, subsequent energy intake and inflammatory markers, we undertook a clinical study of crossover design to investigate the short-term changes on energy intake, subjective appetite ratings, appetite hormones, inflammation markers and glucose metabolism after caffeinated and decaffeinated coffee consumption.

Interventions

OTHERcaffeinated and decaffeinated coffee

3 treatments on separate days, i.e. a standard breakfast with oral ingestion of 200 ml of either caffeinated coffee (3mg caffeine/kg body weight), decaffeinated coffee or water

Sponsors

Beth Israel Deaconess Medical Center
CollaboratorOTHER
Harokopio University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy * non-obese

Exclusion criteria

* smokers * restrained eaters (as this was evaluated using the Dutch Eating Behaviour Questionnaire and a total score \> 2.5) * those who reported slimming or any other dietary regime * abstainers from caffeine sources * athletes during competition period * participants with a known diagnosis of either hypertension, diabetes, impaired glucose tolerance or a fasting blood glucose concentration above 125 mg/dl * subjects on medication for hypertension or on medication known to alter glucose metabolism * subjects who were on medication that may have an impact on appetite and sensory functioning or who reported a metabolic or endocrine disease, gastrointestinal disorders, or a history of medical or surgical events that may have affected the study outcomes

Design outcomes

Primary

MeasureTime frameDescription
Total Energy Intake1 dthe energy consumed at breakfast, ad libitum meal and rest of the experimental day
Ghrelin Total Area Under the Curve15 min before ingestion to 3 hr post ingestionTotal area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.
Peptide Tyrosine Tyrosine (PYY) Total Area Under the Curve15 min before ingestion to 3 hr post ingestionTotal area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.
Glucagon-like Peptide-1 (GLP-1) Total Area Under the Curve15 min before ingestion to 3 hr post ingestionTotal area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.
Adiponectin Total Area Under the Curve15 min before ingestion to 3 h post ingestionTotal area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.
Inteleukin-6 Total Area Under the Curve15 min before ingestion to 3 hr post ingestionTotal area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.
Interleukin-18 Total Area Under the Curve15 min before ingestion to 3 hr post ingestionTotal area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.
Glucose Total Area Under the Curve15 min before ingestion to 3 hr post ingestionTotal area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.
Insulin Total Area Under the Curve15 min before ingestion to 3 hr post ingestionTotal area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.
Cortisol Total Area Under the Curve15 min before ingestion to 3 hr post ingestionTotal area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.
Energy ad Libitum Meal3 hr post ingestionThe energy of first meal 3 hr after ingestion

Secondary

MeasureTime frameDescription
Serum Antioxidant Capacity Total Area Under the Curve15 min before ingestion to 21/2 hr post ingestionSerum samples, collected 15 min before ingestion, immediately after ingestion, 15 min, 30 min, 60 min, 90 min, 120 min and 150 min after ingestion were analyzed for the ex vivo serum resistance to oxidative stress, that was induced by copper sulfate (CuSO4). The analysis of all collected samples was performed by the measurement of conjugated diene formation, which was monitored for every sample of all time points every 2 min for a 3.5 h period at 234 nm in a microplate spectrophotometer. Total area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150 min postconsumption.

Countries

Greece

Participant flow

Recruitment details

February-Mai 2009, Athens region, voluntarily recruitment

Participants by arm

ArmCount
Group 116
Total16

Baseline characteristics

CharacteristicGroup 1
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
16 Participants
Age Continuous27.8 years
STANDARD_DEVIATION 5.2
Region of Enrollment
Greece
16 participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 160 / 160 / 16
serious
Total, serious adverse events
0 / 160 / 160 / 16

Outcome results

Primary

Adiponectin Total Area Under the Curve

Total area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.

Time frame: 15 min before ingestion to 3 h post ingestion

ArmMeasureValue (MEAN)Dispersion
Caffeinated CoffeeAdiponectin Total Area Under the Curve22.7 ug*h/mLStandard Deviation 8.8
Decaffeinated CoffeeAdiponectin Total Area Under the Curve22.6 ug*h/mLStandard Deviation 10.2
WaterAdiponectin Total Area Under the Curve22.6 ug*h/mLStandard Deviation 11
Primary

Cortisol Total Area Under the Curve

Total area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.

Time frame: 15 min before ingestion to 3 hr post ingestion

ArmMeasureValue (MEAN)Dispersion
Caffeinated CoffeeCortisol Total Area Under the Curve43.2 ug*h/dLStandard Deviation 11.3
Decaffeinated CoffeeCortisol Total Area Under the Curve39.8 ug*h/dLStandard Deviation 10.5
WaterCortisol Total Area Under the Curve35.0 ug*h/dLStandard Deviation 6.9
Primary

Energy ad Libitum Meal

The energy of first meal 3 hr after ingestion

Time frame: 3 hr post ingestion

ArmMeasureValue (MEAN)Dispersion
Caffeinated CoffeeEnergy ad Libitum Meal1749 kcalStandard Deviation 407
Decaffeinated CoffeeEnergy ad Libitum Meal1720 kcalStandard Deviation 402
WaterEnergy ad Libitum Meal1750 kcalStandard Deviation 442
Primary

Ghrelin Total Area Under the Curve

Total area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.

Time frame: 15 min before ingestion to 3 hr post ingestion

ArmMeasureValue (MEAN)Dispersion
Caffeinated CoffeeGhrelin Total Area Under the Curve2669 ug*h/mLStandard Deviation 786
Decaffeinated CoffeeGhrelin Total Area Under the Curve2593 ug*h/mLStandard Deviation 778
WaterGhrelin Total Area Under the Curve2672 ug*h/mLStandard Deviation 902
Primary

Glucagon-like Peptide-1 (GLP-1) Total Area Under the Curve

Total area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.

Time frame: 15 min before ingestion to 3 hr post ingestion

ArmMeasureValue (MEAN)Dispersion
Caffeinated CoffeeGlucagon-like Peptide-1 (GLP-1) Total Area Under the Curve43 ug*h/mLStandard Deviation 61
Decaffeinated CoffeeGlucagon-like Peptide-1 (GLP-1) Total Area Under the Curve45 ug*h/mLStandard Deviation 69
WaterGlucagon-like Peptide-1 (GLP-1) Total Area Under the Curve61 ug*h/mLStandard Deviation 122
Primary

Glucose Total Area Under the Curve

Total area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.

Time frame: 15 min before ingestion to 3 hr post ingestion

ArmMeasureValue (MEAN)Dispersion
Caffeinated CoffeeGlucose Total Area Under the Curve336 mg*h/dlStandard Deviation 22
Decaffeinated CoffeeGlucose Total Area Under the Curve329 mg*h/dlStandard Deviation 20
WaterGlucose Total Area Under the Curve323 mg*h/dlStandard Deviation 20
Primary

Insulin Total Area Under the Curve

Total area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.

Time frame: 15 min before ingestion to 3 hr post ingestion

ArmMeasureValue (MEAN)Dispersion
Caffeinated CoffeeInsulin Total Area Under the Curve54 uU*h/mlStandard Deviation 14
Decaffeinated CoffeeInsulin Total Area Under the Curve52 uU*h/mlStandard Deviation 16
WaterInsulin Total Area Under the Curve52 uU*h/mlStandard Deviation 16
Primary

Inteleukin-6 Total Area Under the Curve

Total area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.

Time frame: 15 min before ingestion to 3 hr post ingestion

ArmMeasureValue (MEAN)Dispersion
Caffeinated CoffeeInteleukin-6 Total Area Under the Curve5.4 pg*h/mLStandard Deviation 2.1
Decaffeinated CoffeeInteleukin-6 Total Area Under the Curve5.5 pg*h/mLStandard Deviation 2.5
WaterInteleukin-6 Total Area Under the Curve6.0 pg*h/mLStandard Deviation 2.6
Primary

Interleukin-18 Total Area Under the Curve

Total area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.

Time frame: 15 min before ingestion to 3 hr post ingestion

ArmMeasureValue (MEAN)Dispersion
Caffeinated CoffeeInterleukin-18 Total Area Under the Curve818 pg*h/mLStandard Deviation 289
Decaffeinated CoffeeInterleukin-18 Total Area Under the Curve777 pg*h/mLStandard Deviation 280
WaterInterleukin-18 Total Area Under the Curve786 pg*h/mLStandard Deviation 273
Primary

Peptide Tyrosine Tyrosine (PYY) Total Area Under the Curve

Total area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150, 180 min postconsumption.

Time frame: 15 min before ingestion to 3 hr post ingestion

ArmMeasureValue (MEAN)Dispersion
Caffeinated CoffeePeptide Tyrosine Tyrosine (PYY) Total Area Under the Curve251 pg*h/mLStandard Deviation 136
Decaffeinated CoffeePeptide Tyrosine Tyrosine (PYY) Total Area Under the Curve286 pg*h/mLStandard Deviation 138
WaterPeptide Tyrosine Tyrosine (PYY) Total Area Under the Curve259 pg*h/mLStandard Deviation 158
Primary

Total Energy Intake

the energy consumed at breakfast, ad libitum meal and rest of the experimental day

Time frame: 1 d

ArmMeasureValue (MEAN)Dispersion
Caffeinated CoffeeTotal Energy Intake3223 kcalStandard Deviation 735
Decaffeinated CoffeeTotal Energy Intake3445 kcalStandard Deviation 871
WaterTotal Energy Intake3302 kcalStandard Deviation 971
Secondary

Serum Antioxidant Capacity Total Area Under the Curve

Serum samples, collected 15 min before ingestion, immediately after ingestion, 15 min, 30 min, 60 min, 90 min, 120 min and 150 min after ingestion were analyzed for the ex vivo serum resistance to oxidative stress, that was induced by copper sulfate (CuSO4). The analysis of all collected samples was performed by the measurement of conjugated diene formation, which was monitored for every sample of all time points every 2 min for a 3.5 h period at 234 nm in a microplate spectrophotometer. Total area under the curve was defined as the sum of the areas under and over the baseline using the trapezoidal rule. The time points for the calculations were 15 min before beverage consumption, immediately after beverage consumption, 15, 30, 60, 90, 120, 150 min postconsumption.

Time frame: 15 min before ingestion to 21/2 hr post ingestion

ArmMeasureValue (MEAN)Dispersion
Caffeinated CoffeeSerum Antioxidant Capacity Total Area Under the Curve102 lag time (min) *hStandard Deviation 30
Decaffeinated CoffeeSerum Antioxidant Capacity Total Area Under the Curve104 lag time (min) *hStandard Deviation 37
WaterSerum Antioxidant Capacity Total Area Under the Curve108 lag time (min) *hStandard Deviation 32

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026